Harro Seelaar

Dr. Harro Seelaar is an Assistant Professor in the Department of Neurology at Erasmus MC, a leading medical university in the Netherlands. He is actively engaged in research on neurodegenerative disorders, with a primary focus on frontotemporal dementia (FTD) and its genetic underpinnings. His work spans clinical, genetic, and neuropsychological domains, contributing to major international collaborations and national initiatives such as the ABOARD cohort for dementia research.

His research interests center on frontotemporal dementia, frontotemporal lobar degeneration, genetic risk factors (including C9orf72 and UNC13A), and neuropsychological profiling in presymptomatic and symptomatic stages of disease. He investigates how genetic variants influence disease presentation, progression, and survival, often employing large-scale genomic and meta-analytic approaches.

The most recent publications highlight trends in genetic sequencing, neurobehavioral assessment, and cohort-based clinical research. His work frequently appears in high-impact journals such as Nature Communications and Annals of Neurology, reflecting a strong focus on translational neuroscience and precision medicine in dementia.

Dr. Seelaar has supervised doctoral work, as indicated by the 'Supervised Work (3)' on his profile, and is involved in mentoring early-career researchers. He participates in multi-institutional grants and collaborative networks, particularly in the fields of FTD and ALS research, though specific grant details are not listed in the source text.

He is part of research teams contributing to national and international efforts in dementia, including genetic consortia and clinical trial networks. His lab or research group is embedded within the Neurology department at Erasmus MC, focusing on biomarker discovery, genetic analysis, and cognitive phenotyping in neurodegenerative diseases.